Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇲🇽MX · Medicine#1321K to 10K
- 🇦🇪AE · Medicine#148500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
750 to 6.5K🎙 ~2x weekly·75 episodes·Last published 1w ago - Monthly Reach
Unique listeners across all episodes (30 days)
1.5K to 13K🇲🇽77%🇦🇪23% - Active Followers
Loyal subscribers who consistently listen
600 to 5.2K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 13 epsHosts
Recent guests
Recent episodes
TMVII: Understanding the Emergence of Trichophyton mentagrophytes Genotype VII – Dr Jason Zucker
Jun 16, 2026
19m 54s
Special Episode - Latest Update on Emerging Infections and Health Threats
Jun 12, 2026
1h 02m 15s
From Data to Guidance: The Process Behind Clinical Guidelines – Dr Rajesh Gandhi
Jun 2, 2026
30m 40s
Management of Hepatitis B Virus Infection and Vaccination – Dr Debika Bhattacharya
May 19, 2026
32m 35s
The Impact of Long-acting Injectable HIV Treatments on Public Health – Dr Kelly Gebo
May 5, 2026
26m 43s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/16/26 | TMVII: Understanding the Emergence of Trichophyton mentagrophytes Genotype VII – Dr Jason Zucker | In episode 80 of Going anti-Viral, Dr Jason Zucker joins host Dr Michael Saag to provide an update on the Trichophyton mentagrophytes genotype VII (TMVII) infection. Dr Zucker is an Assistant Professor of Medicine at Columbia University and Assistant Medical Director of the New York City STD Prevention Training Center. Dr Zucker is an experienced HIV, HIV prevention, and sexual health care provider providing status-neutral care to patients of all ages in New York. His research focuses on the ... | 19m 54s | ||||||
| 6/12/26 | Special Episode - Latest Update on Emerging Infections and Health Threats✨ | emerging infectionspublic health challenges+3 | — | IAS–USAEmory University School of Medicine | — | emerging infectionshealth threats+3 | — | 1h 02m 15s | |
| 6/2/26 | From Data to Guidance: The Process Behind Clinical Guidelines – Dr Rajesh Gandhi✨ | clinical guidelineshealthcare+3 | Dr Rajesh T. Gandhi | Harvard Medical SchoolHarvard University Center for AIDS Research+2 | — | clinical guidelinesDr Rajesh T. Gandhi+3 | — | 30m 40s | |
| 5/19/26 | Management of Hepatitis B Virus Infection and Vaccination – Dr Debika Bhattacharya✨ | Hepatitis BViral infection management+3 | Dr Debika Bhattacharya | University of California Los Angeles (UCLA)UCLA David Geffen School of Medicine | — | Hepatitis BHBV+5 | — | 32m 35s | |
| 5/5/26 | The Impact of Long-acting Injectable HIV Treatments on Public Health – Dr Kelly Gebo✨ | HIV treatmentspublic health+3 | Dr Kelly Gebo | Milken Institute School of Public HealthGeorge Washington University | — | HIVlong-acting injectable treatments+3 | — | 26m 43s | |
| 4/21/26 | Cognitive Aging in HIV: Clinical Assessment and Management – Dr Shibani Mukerji✨ | Cognitive AgingHIV+4 | Dr Shibani Mukerji | Harvard Medical SchoolMassachusetts General Hospital | — | Cognitive AgingHIV+5 | — | 37m 22s | |
| 4/7/26 | Immunology of HIV Cure and Beyond: Navigating Immunology Presentations at CROI 2026 – Dr John Frater✨ | HIV CureImmunology+3 | Dr John Frater | University of Oxford | — | HIVImmunology+4 | — | 27m 35s | |
| 3/24/26 | Neurodegeneration and Dementia Risk in Older Adults with HIV: Biomarkers and Epidemiology – Dr Alan Winston✨ | HIVneurodegeneration+4 | Dr Alan Winston | Imperial College LondonSt. Mary's Hospital, London | — | HIVdementia+5 | — | 28m 15s | |
| 3/10/26 | CROI 2026 Review: What’s New, What’s Next in HIV Research – Dr Peter Hunt✨ | HIV researchCROI 2026+3 | Dr Peter Hunt | University of California San FranciscoZuckerberg San Francisco General Hospital+1 | — | HIVCROI+3 | — | 31m 53s | |
| 2/28/26 | From Wall Street to ACT UP: A Life Rewritten by HIV - Peter Staley✨ | HIV activismLGBTQ+ rights+3 | Peter Staley | ACT UPConference on Retroviruses and Opportunistic Infections+1 | — | HIVAIDS+5 | — | 41m 31s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 2/25/26 | Successes in HIV-1 Vaccine Design: Accelerating Completion of One of Sciences’ Most Difficult Vaccines – Dr Kevin Saunders✨ | HIV-1 Vaccine DesignImmunology+3 | Dr Kevin Saunders | Duke Human Vaccine InstituteConference on Retroviruses and Opportunistic Infections | — | HIV-1vaccine design+5 | — | 27m 56s | |
| 2/19/26 | Strategic and Resilient Responses to the Funding Crisis Across Africa – Dr Ruanne Barnabas✨ | funding crisisAfrica+3 | Dr Ruanne Barnabas | Massachusetts General Hospital | — | funding crisisAfrica+4 | — | 24m 17s | |
| 2/10/26 | Reflections on a Career of HIV Medicine, Mentorship, and Scientific Legacy – Dr Martin Hirsch✨ | HIV medicinementorship+3 | Dr Martin Hirsch | Harvard Medical SchoolHarvard Collaborative AIDS Treatment Evaluation Unit+1 | — | HIVmedicine+4 | — | 34m 57s | |
| 1/27/26 | Preview of the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) | In episode 66 of Going anti-Viral, Dr Nicolas Chomont joins host Dr Michael Saag to provide a preview of the 2026 Conference on Retroviruses and Opportunistic Infections (CROI). Dr Chomont is Chair of the Scientific Program Committee for CROI 2026 and is a Professor in the Department of Microbiology, Infectious Diseases, and Immunology at the Université de Montréal and a researcher at the CHUM Research Centre. Dr Chomont discusses CROI 2026, highlighting its significance in advancing HIV rese... | 22m 44s | ||||||
| 1/13/26 | IAS-USA Lifetime of Leadership Award – Dr Gerald Friedland | In episode 65 of Going anti-Viral, Dr Gerald Friedland joins host Dr Michael Saag as the recipient of the IAS–USA Lifetime of Leadership Award, established nearly 15 years ago to honor individuals whose contributions have left a profound and lasting impact on HIV medicine, scientific education, and the mission of the IAS–USA. Dr Friedland discusses his extensive journey in the field of HIV/AIDS and infectious diseases, reflecting on his early career, the challenges faced during the early year... | 34m 53s | ||||||
| 12/23/25 | Going anti-Viral 2025 – The Remarkable Outcomes of Scientific Research | In episode 64 of Going anti-Viral, we look back at the past year and beyond to share highlights from past episodes of the Going anti-Viral Podcast. In this selection of highlights, we share the remarkable outcomes of scientific research, hearing from researchers, clinicians, and survivors. These outcomes are the result of the tremendous work and innovation of our guests and the entire scientific research community and the investment of the American people in scientific research. 0:00 – ... | 10m 46s | ||||||
| 12/16/25 | The Role of Outcomes Research on Clinical Decisions for Patient Care – Dr Mari Kitahata | In episode 63 of Going anti-Viral, Dr Mari Kitahata joins host Dr Michael Saag to discuss the role of outcomes research on clinical decisions for patient care. Dr Kitahata is a Professor of Medicine at the University of Washington (UW) in the Division of Allergy and Infectious Diseases. For more than 3 decades, she has directed the UW/Fred Hutch Center for AIDS Research (CFAR) Clinical Research Core. Dr Kitahata’s research focuses on improving long-term outcomes for people with HIV and she ha... | 37m 40s | ||||||
| 12/2/25 | The COVID-19 Pandemic and the Current State of Public Health in the US – Dr Rochelle Walensky | In episode 62 of Going anti-Viral, Dr Rochelle Walensky joins host Dr Michael Saag on World AIDS Day 2025 to discuss her experience as the Director of the Centers for Disease Control and Prevention (CDC) during the COVID-19 pandemic and the current state of public health in the United States. Dr Walensky is a Professor of Medicine at Harvard Medical School and has published over 300 research articles that have motivated changes to US HIV testing and immigration policy and promoted expanded fu... | 34m 41s | ||||||
| 11/18/25 | The Evidence for Vaccine Safety and Effectiveness – Dr Yvonne Maldonado | In episode 61 of Going anti-Viral, Dr Yvonne Maldonado joins host Dr Michael Saag to discuss the evidence for vaccine safety and effectiveness. Dr Maldonado is a Professor in the Stanford University School of Medicine where she has achieved national and international recognition for her scholarship in the epidemiology and control of infectious diseases. She has served on several national and international committees including, until recently, the CDC Advisory Committee on Immunization Practic... | 39m 10s | ||||||
| 11/4/25 | Medical Cannabis: Evidence and Insight with Dr Donald Abrams | In episode 60 of Going anti-Viral, Dr Donald Abrams joins host Dr Michael Saag to discuss medical cannabis. Dr Abrams is a professor emeritus at the University of California San Francisco and a specialist in integrative oncology at the Osher Center for Integrative Health. Dr Abrams has studied complementary and alternative therapies, including mind-body treatments, botanical therapies, medical use of cannabis and herbal therapies used in traditional Chinese medicine. He continues to research ... | 29m 34s | ||||||
| 10/21/25 | The CDC without Scientific Leadership - Dr Demetre Daskalakis | In episode 59 of Going anti-Viral, Dr Demetre Daskalakis joins host Dr Michael Saag to discuss his career in public health and the turnover in leadership at the US Centers for Disease Control and Prevention (CDC). Dr Daskalakis is an infectious diseases physician who served in leadership roles at the CDC from 2020 to 2025. He was director of the National Center for Immunization and Respiratory Diseases and was previously director of the Division of HIV Prevention at the National Center for HI... | 37m 18s | ||||||
| 10/7/25 | Demystifying Syphilis: Diagnosis and Treatment – Dr Khalil Ghanem | In episode 58 of Going anti-Viral, Dr Khalil Ghanem joins host Dr Michael Saag to discuss current challenges in the diagnosis and treatment of syphilis. Dr Ghanem is a Professor of Medicine in the Division of Infectious Diseases at Johns Hopkins University School of Medicine. Dr Ghanem’s research focuses on reproductive tract infections in particular syphilis and the vaginal microbiome. He was a consultant to the Centers for Disease Control and Prevention on the development of the 2010 and 20... | 30m 50s | ||||||
| 9/23/25 | A Personal Journey with HIV and Advocacy for HIV Research – Dawn Averitt | In episode 57 of Going anti-Viral, Dawn Averitt joins host Dr Michael Saag to discuss HIV advocacy and the importance of scientific research. Ms Averitt is a social justice advocate and founder of organizations focused on women with HIV and AIDS such as the Well Project and the Women’s Information Service and Exchange. Ms Averitt has served on several scientific and advisory committees, including 2 terms on the President’s Advisory Council on HIV/AIDS, and has been responsible for key achieve... | 30m 31s | ||||||
| 9/9/25 | The Management of Cardiovascular Health in Patients with HIV – Dr Steven Grinspoon | In episode 56 of Going anti-Viral, Dr Steven Grinspoon joins host Dr Michael Saag to discuss managing cardiovascular health in people with HIV. Dr Grinspoon is a clinician in the Neuroendocrine and Pituitary Tumor Clinical Center and faculty member at the Massachusetts General Hospital, and a Professor of Medicine at Harvard Medical School. He is a clinical researcher who studies hypothalamic control of body weight and fat distribution in obesity and lipodystrophy with a focus on the metaboli... | 27m 24s | ||||||
Showing 24 of 81
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.